Addressing GLP-1 Access Inequity: Lessons from ...

By João L. Carapinha

September 19, 2025

The BMJ article by Ratevosian and Sturchio asserts that GLP-1 access inequity is becoming emblematic of global health disparity. This is driven by high costs and limited availability, particularly in low- and middle-income countries. Drawing lesso...
CAPVAXIVE Pneumococcal Vaccine Delivers Strong Immune Response in At-Risk Youth
FDA Guidance on Overall Survival Assessment in Oncology Trials
Sanofi’s Rilzabrutinib Receives Orphan Designation for IgG4-Related Dis...
MAF Test Breast Cancer: Revolutionizing Personalized Treatment in Spanish Onc...
NICE’s Ribociclib Breast Cancer Guidance: A New Era for High-Risk Patie...
T1 Diabetes Care with an Implantable Glucose Device
Lenacapavir HIV Prevention: Gilead’s Strategic Agreement to Enhance Acc...
Cell Therapy for Type 1 Diabetes: Vertex Trial Results and Market Potential
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
Alzheimer’s Blood Test Diagnostics: FDA Clears First Blood Test for Ear...
High Orphan Drug Prices Persist Despite Market Exclusivity Expiration
Ivonescimab NMPA Approval Signals Breakthrough in Lung Cancer